# Impact of Exenatide on Sleep Duration

> **NCT01416649** · — · COMPLETED · sponsor: **University of Chicago** · enrollment: 8 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Exenatide

## Key facts

- **NCT ID:** NCT01416649
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02-01
- **Primary completion:** 2021-04-21
- **Final completion:** 2021-04-21
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2023-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01416649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01416649, "Impact of Exenatide on Sleep Duration". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01416649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*